You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025
- 2. Case report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma
- 3. Study identifies key features of cancer cell response and resistance to treatment
- 4. Molecular test personalises prostate cancer treatment
- 5. Potential application of nanodelivery systems targeting ELAVL1 in prostate cancer treatment
- 6. Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticity
- 7. Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors
- 8. "This Is How We Do It" Star Montell Jordan Opens Up About His Prostate Cancer Journey As Part of Powerful New Partnership with ZERO Prostate Cancer
- 9. Deep learning in breast cancer risk prediction: a review of recent applications in full-field digital mammography
- 10. Key parameters in intratumoral-peritumoral region fusion models: optimizing deep learning radiomics for breast cancer diagnosis
Last updated at 11:21 GMT
Hot News Makers
Health/Pharma Companies
-
73516.23
-
60996.80
-
16251.68
-
15351.20
-
13735.91
-
8891.53
-
4557.73
-
4289.61
-
3963.40
-
3430.90
Drugs, Treatments, Trials
-
11344.97
-
8751.47
-
6434.75
-
6182.78
-
4507.00
-
1562.90
-
1409.82
-
1172.17
-
839.06
-
756.22
Last updated at 11:10 GMT
